Zealand Pharma submits New Drug Application to US FDA for dasiglucagon in congenital hyperinsulinism

https://www.globenewswire.com/news-release/2023/06/30/2698007/0/en/Zealand-Pharma-submits-New-Drug-Application-to-US-FDA-for-dasiglucagon-in-congenital-hyperinsulinism.html

press release